BASKHANBIOPharma Inc.
354390 | KO
Overview
Corporate Details
- ISIN(s):
- KR7354390007
- LEI:
- Country:
- South Korea
- Address:
- 경기도 안성시 원곡면 원당로 354, 안성시
- Website:
- http://www.baskhanbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-01 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-06-25 00:00 |
Report Publication Announcement
기업설명회(IR)개최결과
|
Korean | 6.6 KB | ||
| 2025-06-10 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2025-03-31 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 134.8 KB | ||
| 2025-03-27 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.3 KB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 23.9 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 375.9 KB | ||
| 2025-03-11 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 9.6 KB | ||
| 2025-03-11 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 101.6 KB | ||
| 2025-02-19 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 14.4 KB | ||
| 2024-12-12 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.4 KB | ||
| 2024-12-05 00:00 |
AGM Information
임시주주총회결과
|
Korean | 5.4 KB | ||
| 2024-11-20 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 38.7 KB | ||
| 2024-11-13 00:00 |
Regulatory Filings
기업설명회(IR)개최결과
|
Korean | 6.6 KB | ||
| 2024-10-29 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.0 KB |
Automate Your Workflow. Get a real-time feed of all BASKHANBIOPharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for BASKHANBIOPharma Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BASKHANBIOPharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
United Kingdom
ANAN
Türkiye
ANGEN
Developing precision therapeutics for neurodegenerative and CNS disorders.
United States of America
AVXL
United States of America
AVXL
Develops and supplies in vitro diagnostic solutions for human and veterinary markets.
United States of America
NNNN
United States of America
NNNN
Clinical-stage biotech developing an antidote for acute cannabinoid intoxication in ER patients.
United States of America
ANEB
United States of America
ANEB
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan
4563
Japan
4563
Develops joint preservation and regenerative solutions for early intervention orthopedic care.
United States of America
ANIK
United States of America
ANIK
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom
ANCR
United Kingdom
ANCR
Develops, manufactures, and markets branded/generic drugs and OTCs for niche therapeutic areas.
United States of America
ANIP
United States of America
ANIP
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden
ANNX
Sweden
ANNX